NSCLC

Study finds how type of allergy remedy help treat lung cancer

Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC). In preliminary human research, combining immunotherapy with dupilumab - an Interleukin-4 (IL-4) receptor-blocking antibody widely used to treat allergies and asthma -...